|
Home
About
Us
Individual
IC Counseling
Support
Group Workshops
For Nutrition Professionals
Newsletter
IC
Diet Resources
Supplements for IC
IC
Shop
Online
Disclaimer
Contact Information:
Julie Beyer, RD
NutraConsults
P.O. Box 210086
Auburn Hills, MI 48348
Email:
Confident
Choices
Phone:
248-961-3613
Confident
Choices is pleased to partner with:
Romans 8:28
|
Popular
Supplements for Interstitial Cystitis
Important Legal Disclaimer: The
information presented here is not medical advice. Treatment of
interstitial cystitis is highly individualized. Drug interactions
are becoming more common as people have access to more
over-the-counter medications and alternative options for
treatments. Individual patients may have co-existing conditions
that could be complicated by the use of “natural” treatments.
No recommendations for use or dosages are provided or implied
below. We strongly urge you to contact your physician for
information regarding any change you wish to make in your
lifestyle.
|
L-Arginine
- 500mg
Research studies have found that L-Arginine has been helpful in the
reduction of some IC symptoms. In 1999, a double-blind study using
1.5 grams of arginine for three months in a group of women with
interstitial cystitis, reported considerable improvement compared
with the effect of a placebo in a variety of indices. Although other
research results are somewhat contradictory, this supplement
may help.
|
Algonot's Cystoprotek
Cystoprotek
contains quercetin, chondroitin sulfate & glucosamine, and
also includes Kernel Olive Oil (to increase absorption) and Sodium
Hyaluronate which has been used as a bladder
coating.
|
Prelief
Prelief
is a dietary supplement that helps patients who are sensitive to
acid. Made of calcium glycerophosphate, it is taken with meals and
at bed time. 120 tablets in a bottle
This
is the most popular acid reducing supplement used by both IC and IBS
patients.
Supplement Facts:
calcium 130mg, phosphorus 100mg
Ingredients: calcium glycerophosphate, magnesium stearate
|
|
CystaQ CystaQ
is the oldest alternative available to
patients today!
Farr
Laboratories has played the key role in develop a propriety blend
of quercetin (and products using quercetin) for bladder syndromes.
They have also conducted research studies with IC and prostatitis
patients that demonstrate success in reducing symptoms
60
capsules
540 mgs.
Contains Quercetin, Bromelain, Papain, Black Cohosh, Skullcap,
Wood Betony, Passionflower, Valerian & Cranberry Powder.
Please note that the cranberry is not in an acidic form.
|
 
pH Choice and pH Control
pH
Choice is the acid reducing Alka-Plex™ formula that comes as
granules in a shaker bottle for sprinkling on prepared foods, adding
to beverages and adding to recipes. The instant it touches foods or
beverages, hot or cold, pH Choice neutralizes the acid! pH Choice
does not affect the taste, flavor or aroma of foods and beverages.
pH Control is designed to pass through the stomach
without dissolving and deliver an effective, natural and safe acid
neutralizer into the intestinal tract where it can be absorbed into
the body fluids and be carried into the bladder and urinary tract.
The effectiveness of pH Control™ has been proven in laboratory
testing and pre-clinical studies.
The key active ingredient is a potassium-based strong alkalizer that
is combined with a calcium-based weak alkalizer. Other, inactive
ingredients include Cellulose Gum.
Contains NO yeast, wheat, corn, milk, egg, soy, glutens, artificial
colors, sugar, starch, preservatives or flavoring.
|
Desert
Harvest Aloe
One of the most researched supplements created
especially for IC patients!
Each
Desert Harvest aloe vera capsule contains 600 milligrams of freeze-
dried aloe vera from the whole leaf and contains 200 mg. of
mucopolysaccharide (MPS), the active ingredient in the aloe plant.
This is 'cold processed'. All of the water and most of the fiber has
been morved. It is not a laxative, as the aloin and aloe emodin is
removed.
In a double blind, placebo controlled clinical trial in IC patients,
87.% of participants received relief from atleast one symptom of
their IC. 50% received relief from all or most of their symptoms.
Only one patient did not respond within 30 days.
|
|
